Dementia

Scientists from McGill University are suggesting a novel microdose formulation of lithium could not only slow the progression of Alzheimer’s disease in its initial stages but potentially improve cognition at the early stages of decline.

A study is suggesting a previously unknown protein may play a role in the pathogenesis of Alzheimer’s. The study claims this protein facilitates the formation of the amyloid plaques thought to cause the neurodegeneration associated with the disease.

Utilizing a recently developed brain imaging technique new research suggests measuring accumulated levels of a protein called tau may predict future neurodegeneration associated with Alzheimer’s disease.

A new study has described the successful results in mice of a novel vaccine designed to prevent neurodegeneration associated with Alzheimer’s disease. The researchers suggest this "dementia vaccine" could become the “breakthrough of the next decade.”

New research, led by scientists from the University of Rochester, has homed in on a mechanism responsible for causing the cognitive impairment seen in patients who receive cranial radiotherapy for brain cancer.

Scientists are homing in on exactly how two experimental Alzheimer’s drugs may be generating the anti-aging effects seen in animal studies. The discovery of a unique metabolic pathway offers researchers novel directions for future anti-aging studies.

Two compelling new studies are building on a hypothesis suggesting age-related dementia is caused by a leaky blood-brain barrier. Experts suggest the studies are interesting but not particularly applicable to human cases of dementia.

A team of international researchers has achieved a world-first breakthrough, decades in the making, creating artificial neurons with the ability to behave exactly like real living neurons. The innovation has potential for treating numerous diseases.

Chinese authorities recently approved a novel drug claimed to improve cognitive function in patients with Alzheimer’s disease. Derived from a seaweed, it's suggested to reduce neuroinflammation by modulating a person’s gut microbiome.

In an unusual turn of events a new Alzheimer’s drug, previously declared a failure in March, has been resurrected with the pharmaceutical company behind the treatment suggesting the earlier decision was premature and based on incorrect data analysis.

Scientists in Australia have identified an enzyme that appears to play a role in two key drivers of Alzheimer's.

Clinicians soon may be able to accurately diagnose what kind of dementia patients are suffering from by studying their unique walking patterns.